Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001193125-25-030794
Filing Date
2025-02-20
Accepted
2025-02-20 16:53:21
Documents
3

Document Format Files

Seq Description Document Type Size
1 424B3 d812844d424b3.htm 424B3 24542
2 GRAPHIC g812808g0220201824652.jpg GRAPHIC 2573
3 GRAPHIC g812844g0220144541335.jpg GRAPHIC 3481
  Complete submission text file 0001193125-25-030794.txt   34392
Mailing Address THREE INTERNATIONAL TOWERS LEVEL 24, 300 BARANGAROO AVENUE SYDNEY NSW C3 2000
Business Address THREE INTERNATIONAL TOWERS LEVEL 24, 300 BARANGAROO AVENUE SYDNEY NSW C3 2000 01161298780088
KAZIA THERAPEUTICS LTD (Filer) CIK: 0001075880 (see all company filings)

EIN.: 000000000 | State of Incorp.: C3 | Fiscal Year End: 0630
Type: 424B3 | Act: 33 | File No.: 333-276774 | Film No.: 25646305
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)